Accolade (Accolade) Total Inventories : $0.0 Mil (As of Nov. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Accolade Total Inventories?

Accolade's total inventories for the quarter that ended in Nov. 2023 was $0.0 Mil. Accolade's average total inventories from the quarter that ended in Aug. 2023 to the quarter that ended in Nov. 2023 was $0.0 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Accolade's Net-Net Working Capital per share for the quarter that ended in Nov. 2023 was $-1.34.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Accolade's Days Inventory for the three months ended in Nov. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Accolade's Inventory-to-Revenue for the quarter that ended in Nov. 2023 was 0.00.

Accolade Total Inventories Historical Data

The historical data trend for Accolade's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Total Inventories Chart

Accolade Annual Data

Trend

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Total Inventories

Get a 7-Day Free Trial

Accolade Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

Accolade Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Accolade (NAS:ACCD) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Accolade's Net-Net Working Capital Per Share for the quarter that ended in Nov. 2023 is

	Net-Net Working Capital Per Share (Q: Nov. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(230.017	+	0.75 * 23.195	+	0.5 * 0	-	350.752
-	0	-	0)	/	76.9664
=	-1.34

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Accolade's Days Inventory for the three months ended in Nov. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Nov. 2023 )	/	Cost of Goods Sold (Q: Nov. 2023 )	*	Days in Period
	=	0	/	54.518	*	365 / 4
	=	0.00

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Accolade's Inventory Turnover for the quarter that ended in Nov. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Nov. 2023 )	/	Average Total Inventories (Q: Nov. 2023 )
	=	54.518	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Accolade's Inventory to Revenue for the quarter that ended in Nov. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	0	/	99.371
	=	0.00

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Accolade Total Inventories Related Terms

Thank you for viewing the detailed overview of Accolade's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Accolade (Accolade) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

4NE1:Germany

Address

1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101

Website

https://www.accolade.com

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Executives

Richard Eskew	officer: EVP General Counsel	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Stephen H. Barnes	officer: Chief Financial Officer	C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh	director, officer: Chief Executive Officer	6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh	officer: President	1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Mchugh Colin	officer: Chief Accounting Officer	C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Michael W Hilton	officer: Chief Product Officer	6222 185TH AVE, REDMOND WA 98052
Peter S Klein	director	C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent	director	7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors	director	C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore	director	1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan	director	2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel	director	BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky	director	C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff	director	SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist	director	600 MONTGOMERY STREET, SAN FRANCISCO CA 94111